TMC Life Sciences Bhd (XKLS:0101) Altman Z-Score: 2.73 (As of Jul. 02, 2026) — 19% Below Median


XKLS:0101 TMC Life Sciences Bhd XKLS:0101
62 GF Score
Price RM0.45
GF Value RM0.62
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is TMC Life Sciences Bhd Altman Z-Score?

TMC Life Sciences Bhd XKLS:0101 62 Altman Z-Score is 2.73 as of Jul. 02, 2026, which is 19% below its 10-year median of 3.35. GuruFocus rates XKLS:0101 with a GF Score™ of 62/100 and a GF Value™ of RM0.62 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 660 Healthcare Providers & Services companies, TMC Life Sciences Bhd ranks better than 54.24% on this metric.

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Warning Sign:

Altman Z-score of 2.69 is in the grey area. This implies that the company is under some kind of financial stress. If it is below 1.8, the company may face bankruptcy risk.

TMC Life Sciences Bhd has a Altman Z-Score of 2.73, indicating it is in Grey Zones. This implies that TMC Life Sciences Bhd is in some kind of financial stress. If it is below 1.81, the company may face bankrupcy risk.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for TMC Life Sciences Bhd's Altman Z-Score or its related term are showing as below:

XKLS:0101' s Altman Z-Score Range Over the Past 10 Years
Min: 2.18   Med: 3.35   Max: 20.13
Current: 2.69

During the past 13 years, TMC Life Sciences Bhd's highest Altman Z-Score was 20.13. The lowest was 2.18. And the median was 3.35.


TMC Life Sciences Bhd  (XKLS:0101) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


TMC Life Sciences Bhd Altman Z-Score Related Terms


TMC Life Sciences Bhd Altman Z-Score Historical Data

* Premium members only.

The historical data trend for TMC Life Sciences Bhd's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TMC Life Sciences Bhd Altman Z-Score Chart

TMC Life Sciences Bhd Annual Data
Trend May15 May16 Aug17 Aug18 Aug19 Jun21 Jun22 Jun23 Jun24 Jun25
Altman Z-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.03 2.43 2.83 3.22 2.34

TMC Life Sciences Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.18 2.34 2.41 2.64 2.86

XKLS:0101 vs HCA, THC, DVA: Altman Z-Score Comparison

For the Medical Care Facilities subindustry, TMC Life Sciences Bhd's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TMC Life Sciences Bhd Altman Z-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TMC Life Sciences Bhd's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where TMC Life Sciences Bhd's Altman Z-Score falls into.


XKLS:0101
62GF Score
TMC Life Sciences Bhd XKLS:0101
Altman Z-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TMC Life Sciences Bhd Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

TMC Life Sciences Bhd's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.0795+1.4*0.2131+3.3*0.0268+0.6*3.1674+1.0*0.3486
=2.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Mar. 2026:
Total Assets was RM1,110.0 Mil.
Total Current Assets was RM195.4 Mil.
Total Current Liabilities was RM107.1 Mil.
Retained Earnings was RM236.5 Mil.
Pre-Tax Income was 2.749 + 9.336 + 6.567 + 3.054 = RM21.7 Mil.
Interest Expense was -1.806 + -1.947 + -2.049 + -2.233 = RM-8.0 Mil.
Revenue was 89.701 + 103.497 + 100.477 + 93.273 = RM386.9 Mil.
Market Cap (Today) was RM783.8 Mil.
Total Liabilities was RM247.5 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(195.367 - 107.114)/1110.002
=0.0795

X2=Retained Earnings/Total Assets
=236.544/1110.002
=0.2131

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(21.706 - -8.035)/1110.002
=0.0268

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=783.847/247.472
=3.1674

X5=Revenue/Total Assets
=386.948/1110.002
=0.3486

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

TMC Life Sciences Bhd has a Altman Z-Score of 2.73 indicating it is in Grey Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.

Frequently Asked Questions Learn more about Altman Z-Score →
What does a Altman Z-Score of 2.73 mean?
TMC Life Sciences Bhd (XKLS:0101) has a Altman Z-Score of 2.73 as of Jul. 02, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on TMC Life Sciences Bhd and its competitors. This is 19% below median its historical median of 3.35. Over the past decade, TMC Life Sciences Bhd's Altman Z-Score has ranged from 2.18 to 20.13. According to the industry distribution chart, TMC Life Sciences Bhd ranks #302 out of 660 companies in the Healthcare Providers & Services industry, placing it in the top 45.8%.
Is TMC Life Sciences Bhd's Altman Z-Score too high?
TMC Life Sciences Bhd's current Altman Z-Score of 2.73 is 19% below median its 10-year median of 3.35. Over the past 10 years, this metric has ranged from a low of 2.18 to a high of 20.13. The Healthcare Providers & Services industry median Altman Z-Score is 2.42. TMC Life Sciences Bhd's value of 2.73 is 12.8% above this industry median. Based on the distribution chart, TMC Life Sciences Bhd ranks #302 out of 660 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, TMC Life Sciences Bhd has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TMC Life Sciences Bhd's Altman Z-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, TMC Life Sciences Bhd ranks #302 out of 660 companies for Altman Z-Score. This puts TMC Life Sciences Bhd in the upper half of its industry. The industry median Altman Z-Score is 2.42. TMC Life Sciences Bhd's value of 2.73 is 12.8% above this benchmark. Historically, TMC Life Sciences Bhd's own Altman Z-Score has ranged from 2.18 to 20.13 over the past decade. While the company's 10-year median is 3.35 vs. the industry median of 2.42, TMC Life Sciences Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Healthcare Providers & Services company?
The median Altman Z-Score among Healthcare Providers & Services companies is 2.42, based on 660 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TMC Life Sciences Bhd's current Altman Z-Score of 2.73 is 12.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on TMC Life Sciences Bhd and its competitors. For the Healthcare Providers & Services industry, the median Altman Z-Score is 2.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TMC Life Sciences Bhd's current Altman Z-Score is 2.73, which is 19% below median its own 10-year median of 3.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TMC Life Sciences Bhd stock overvalued right now?
Based on GuruFocus' analysis, TMC Life Sciences Bhd (XKLS:0101) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.62, compared to a current price of RM0.45 — trading 27.4% below its estimated fair value. The current Altman Z-Score is 2.73, which is 19% below median its 10-year median of 3.35 and 12.8% above the Healthcare Providers & Services industry median of 2.42. TMC Life Sciences Bhd's overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For TMC Life Sciences Bhd (XKLS:0101), the current Altman Z-Score is 2.73 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TMC Life Sciences Bhd (XKLS:0101) Overvalued in 2026?

Based on GuruFocus' analysis, TMC Life Sciences Bhd stock appears to be undervalued. The current stock price of RM0.45 is trading 27.4% below its estimated GF Value™ of RM0.62. GuruFocus considers TMC Life Sciences Bhd to be Modestly Undervalued.

Key valuation signals for XKLS:0101:

  • Altman Z-Score: 2.73 (19% below median its 10-year median of 3.35)
  • GF Value™: RM0.62 vs. price of RM0.45 (27.4% below fair value)
  • GF Score™: 62/100 with 3 warning signs
  • Industry Position: 12.8% above the Healthcare Providers & Services median (#302 of 660)

No single metric tells the full story. See the XKLS:0101 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


TMC Life Sciences Bhd Business Description

Address No. 11, PJU 5, Jalan Teknologi, Level 11, Taman Sains, Kota Damansara, Petaling Jaya, SGR, MYS, 47810
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.
62GF Score

Get the complete analysis for XKLS:0101

Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.45
Price
RM0.62
GF Value